Properties (64)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Lymphoma
|
| gptkbp:canBe |
Immune deficiency
|
| gptkbp:canLeadTo |
Secondary cancers
|
| gptkbp:diseaseResistance |
Biopsy
Blood tests Imaging tests |
| gptkbp:hasAbstract |
Fatigue
Fever Night sweats Swollen lymph nodes Weight loss |
| gptkbp:hasCampus |
Infections
Exposure to chemicals Immune system disorders |
| gptkbp:hasCitations |
gptkb:Chemotherapy
Radiation therapy Stem cell transplant |
| gptkbp:hasService |
Varies by type
Can be aggressive Can_be_indolent |
| gptkbp:hasType |
B-cell lymphoma
T-cell lymphoma |
| https://www.w3.org/2000/01/rdf-schema#label |
Non-Hodgkin lymphoma
|
| gptkbp:isAssociatedWith |
gptkb:Epstein-Barr_virus
HIV/AIDS Autoimmune diseases Chronic inflammation Certain infections Chemical_exposure |
| gptkbp:isCharacterizedBy |
Abnormal lymphocytes
Bone marrow involvement Lymph node enlargement |
| gptkbp:isConsidered |
A type of cancer
|
| gptkbp:isCounteredBy |
Lymph nodes
Spleen Bone marrow Other organs |
| gptkbp:isFoundIn |
Adults
Men Older adults People over 60 |
| gptkbp:isInfluencedBy |
Environmental factors
Lifestyle factors Genetic factors |
| gptkbp:isMonitoredBy |
Imaging studies
Blood tests Regular follow-ups |
| gptkbp:isOrganizedBy |
Hodgkin lymphoma
|
| gptkbp:isPartOf |
Hematologic malignancies
Lymphatic system disorders |
| gptkbp:isRelatedTo |
Hodgkin lymphoma
Lymphatic system |
| gptkbp:isStudiedIn |
Clinical trials
|
| gptkbp:isSubjectTo |
Clinical guidelines
Research studies Treatment protocols |
| gptkbp:isUsedFor |
gptkb:CT_scan
MRI Immunotherapy Oncologists Targeted therapy PET scan Aggressive lymphoma Indolent lymphoma |